TITLE

FORMULATION AND EVALUATION OF MOUTH DISSOLVING TABLETS OF THE ETORICOXIB

AUTHOR(S)
Chandira, R. Margret; Venkataeswarlu, B. S.; Kumudhavalli, M. V.; Jayakar, B.
PUB. DATE
April 2010
SOURCE
Pakistan Journal of Pharmaceutical Sciences;Apr2010, Vol. 23 Issue 2, p178
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The demand for mouth dissolving tablets has been growing during the last decade especially for elderly and children who have swallowing difficulties. Etoricoxib is a new non-steroidal anti-inflammatory drug (NSAID) with selective cox-2 inhibitory activity, selective inhibition of cox-2 provides anti-inflammatory and analgesic activity it is commonly used for osteo-arthritis, rheumatoid arthritis, primary dysmenorrhoea, post operative dental pain and acute gout. The main criteria for mouth dissolving tablets are to disintegrate or dissolve rapidly in oral cavity with saliva in 15sec to 60sec with need of water. The disintegrants used should fulfill the criteria by disintegrating the tablets in specified time limit.in the present investigation variety of super disintegrants like primogel, kollidone, Ac-Di-sol, L-HPMC, L-HPC, were selected and tablets were prepared by direct compression method in different concentration like 4% and 8%. The prepared tablets were evaluated for weight variation, hardness, friability, in vitro disintegration time, wetting time, in vitro dissolution study, etc. formulation f-9 shows the lowest disintegration time (44sec) and wetting time (52sec). In vitro dissolution studies revealed that formulation F-9 containning 8% L-HPC showed 97% drug release at the end of 20 min.
ACCESSION #
52292249

 

Related Articles

  • Diclofenac.  // AHFS Consumer Medication Information;Oct2017, p1 

    Diclofenac is used to relieve pain, tenderness, swelling, and stiffness caused by osteoarthritis (arthritis caused by a breakdown of the lining of the joints), rheumatoid arthritis (arthritis caused by swelling of the lining of the joints), and ankylosing spondylitis (arthritis that mainly...

  • Leflunomide tablet 10 mg and 20 mg.  // Pharmacy Today;Nov2005, Vol. 11 Issue 11, p4 

    The article reports on the availability of Leflunomide tablets 10 mg and 20 mg in the market. The products are indicated for reducing the signs and symptoms of rheumatoid arthritis in adults and inhibiting structural damage to joints.

  • Application of Hydrotropic Solubilization in Spectrophotometric Estimation of Lornoxicam from Tablets. Abraham, Sindhu; Deveswaran, Rajamanickam; Furtado, Sharon; Bharath, Srinivasan; Madhavan, Varadharajan // ISRN Otolaryngology;2014, p1 

    Lornoxicam is a selective cyclooxygenase-1 and cyclooxygenase-2 inhibitor that exhibits anti-inflammatory, analgesic, and antipyretic activities. It is used in osteoarthritis and rheumatoid arthritis; and in treatment of postoperative pain and primary dysmenorrhoea. Lornoxicam is completely...

  • Propriétés et spécificités de la nabumétone. Davies, N.M.; McLachlan, A.J. // Drugs;Jan2000 Special Issue, Vol. 59 Issue 1, p25 

    Features and Properties of Nabumetone Nabumetone is a nonsteroidal anti-inflammatory drug (NSAID) of the 2,6-disubstituted naphthylalkanone class. It is a prodrug metabolised to an active metabolite, 6-methoxy-2-naphthylacetic acid (6-MNA), which preferentially inhibits cyclo-oxygenase-2 (COX-2)...

  • Diagnosis and treatment of low back pain. Koes, B. W.; van Tulder, M. W.; Thomas, S. // BMJ: British Medical Journal (International Edition);6/17/2006, Vol. 332 Issue 7555, p1430 

    The article looks at the diagnosis and treatment of acute and chronic low back pain. The diagnostic process of low back pain is focused on specific low back pain, which includes symptoms such as rheumatoid arthritis and hernia nuclei pulposi. The article discusses early identification for...

  • ENHANCEMENT OF DISSOLUTION RATE STUDIES ON SOLID DISPERSION OF ACECLOFENAC. SENTHILKUMAR, K. L.; SIRISHA, Y. // International Journal of Pharma & Bio Sciences;Apr-Jun2011, Vol. 2 Issue 2, pP.70 

    Aceclofenac is a Non- Steroidal Anti Inflammatory drug indicated for the relief of pain and inflammation, associated with rheumatoid arthritis, osteo arthritis, ankylosing, spondylitis. The percentage of dissolution rate of drug released from pure Aceclofenac was obtained 26.48% in 180min. The...

  • NSAIDs and hypertension. Albishri, Jamal // Anaesthesia, Pain & Intensive Care;May-Aug2013, Vol. 17 Issue 2, p171 

    Non-steroidal anti-inflammatory drugs (NSAIDs) are frequently used to alleviate pain of the patients suffering from inflammatory conditions such as osteoarthritis, rheumatoid arthritis, and other painful conditions. An ample amount of studies put forth evidence that NSAIDs reduce the efficiency...

  • Valdecoxib Is Associated with Improved Dyspepsia-Related Health Compared with Nonspecific NSAIDs in Patients with Osteoarthritis or Rheumatoid Arthritis. Rabeneck, Linda; Goldstein, Jay L.; Vu, An; Mayne, Tracy J.; Rublee, Dale A. // American Journal of Gastroenterology;May2005, Vol. 100 Issue 5, p1043 

    OBJECTIVES: Dyspepsia and related gastrointestinal (GI) symptoms are commonly reported by patients taking nonspecific nonsteroidal anti-inflammatory drugs (NSAIDs) and significantly impact treatment effectiveness, cost, and quality of life. This study sought to evaluate dyspepsia-related health...

  • fenbufen.  // Royal Society of Medicine: Medicines;2002, p243 

    This article presents information on fenbufen, a drug that has similar effects to those of aspirin. It is used particularly in the treatment of the pain of rheumatoid arthritis and osteoarthritis. Fenbufen is thought to cause less gastrointestinal bleeding than other nonsteroidal...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics